Immune targets for therapeutic development in depression: towards precision medicine

WC Drevets, GM Wittenberg, ET Bullmore… - Nature reviews Drug …, 2022 - nature.com
Over the past two decades, compelling evidence has emerged indicating that immune
mechanisms can contribute to the pathogenesis of major depressive disorder (MDD) and …

Neuroinflammation and the kynurenine pathway in CNS disease: molecular mechanisms and therapeutic implications

MN Mithaiwala, D Santana-Coelho, GA Porter… - Cells, 2021 - mdpi.com
Diseases of the central nervous system (CNS) remain a significant health, social and
economic problem around the globe. The development of therapeutic strategies for CNS …

Novel drug developmental strategies for treatment‐resistant depression

É Borbély, M Simon, E Fuchs, O Wiborg… - British journal of …, 2022 - Wiley Online Library
Major depressive disorder is a leading cause of disability worldwide. Because conventional
therapies are ineffective in many patients, novel strategies are needed to overcome …

Inflammation, stress and depression: an exploration of ketamine's therapeutic profile

JN Johnston, MS Greenwald, ID Henter, C Kraus… - Drug discovery today, 2023 - Elsevier
Highlights•Chronic stress, depression and inflammation have been consistently
linked.•Stress-induced inflammatory states can contribute to treatment resistance.•Ketamine …

[HTML][HTML] Updated review and meta-analysis of probiotics for the treatment of clinical depression: adjunctive vs. stand-alone treatment

VL Nikolova, AJ Cleare, AH Young… - Journal of clinical medicine, 2021 - mdpi.com
Recent years have seen a rapid increase in the use of gut microbiota-targeting interventions,
such as probiotics, for the treatment of psychiatric disorders. The objective of this update …

Targeting inflammation: a potential approach for the treatment of depression

S Bhatt, T Devadoss, NK Jha, M Baidya, G Gupta… - Metabolic Brain …, 2023 - Springer
Major depressive disorder (MDD) or Depression is one of the serious neuropsychiatric
disorders affecting over 280 million people worldwide. It is 4th important cause of disability …

Neuroinflammatory alterations in trait anxiety: modulatory effects of minocycline

S Rooney, A Sah, MS Unger, M Kharitonova… - Translational …, 2020 - nature.com
High trait anxiety is a substantial risk factor for developing anxiety disorders and depression.
While neuroinflammation has been identified to contribute to stress-induced anxiety, little is …

Brain-immune crosstalk in the treatment of major depressive disorder

I Branchi, S Poggini, L Capuron, F Benedetti… - European …, 2021 - Elsevier
A growing number of studies are pointing out the need for a conceptual shift from a brain-
centered to a body-inclusive approach in mental health research. In this perspective, the link …

Tolerance-inducing effect and properties of innate immune stimulation on chronic stress-induced behavioral abnormalities in mice

Y Gu, T Ye, P Tan, L Tong, J Ji, Y Gu, Z Shen… - Brain, Behavior, and …, 2021 - Elsevier
Over-activation of the innate immune system constitutes a risk factor for the development of
nervous system disorders but may reduce the severity of these disorders by inducing …

Depression interacts with allostatic load to predict cognitive decline in middle age

G Perlman, H Cogo-Moreira, CY Wu… - …, 2022 - Elsevier
Background Allostatic load (AL) indicates the cumulative impact of stress on homeostatic
mechanisms. Depression and AL have been associated with cognitive deficits, but it is …